- Home
- AXON vs TAK Comparison
AXON vs TAK Comparison
Compare AXON & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXON
- TAK
- Stock Information
- Founded
- AXON 1993
- TAK 1781
- Country
- AXON United States
- TAK Japan
- Employees
- AXON N/A
- TAK N/A
- Industry
- AXON Ordnance And Accessories
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- AXON Industrials
- TAK Health Care
- Exchange
- AXON Nasdaq
- TAK Nasdaq
- Market Cap
- AXON 59.0B
- TAK 47.3B
- IPO Year
- AXON N/A
- TAK N/A
- Fundamental
- Price
- AXON $710.59
- TAK $14.45
- Analyst Decision
- AXON Strong Buy
- TAK
- Analyst Count
- AXON 16
- TAK 0
- Target Price
- AXON $804.87
- TAK N/A
- AVG Volume (30 Days)
- AXON 582.7K
- TAK 2.5M
- Earning Date
- AXON 11-06-2025
- TAK 10-30-2025
- Dividend Yield
- AXON N/A
- TAK 3.75%
- EPS Growth
- AXON 5.86
- TAK N/A
- EPS
- AXON 4.04
- TAK 0.59
- Revenue
- AXON $2,391,590,000.00
- TAK $31,053,301,865.00
- Revenue This Year
- AXON $32.72
- TAK $0.18
- Revenue Next Year
- AXON $24.28
- TAK $0.56
- P/E Ratio
- AXON $176.75
- TAK $24.47
- Revenue Growth
- AXON 32.41
- TAK 1.52
- 52 Week Low
- AXON $416.88
- TAK $12.80
- 52 Week High
- AXON $885.92
- TAK $15.69
- Technical
- Relative Strength Index (RSI)
- AXON 40.74
- TAK 36.98
- Support Level
- AXON $705.00
- TAK $14.38
- Resistance Level
- AXON $726.76
- TAK $14.72
- Average True Range (ATR)
- AXON 26.32
- TAK 0.15
- MACD
- AXON -1.61
- TAK -0.06
- Stochastic Oscillator
- AXON 16.44
- TAK 8.33
About AXON Axon Enterprise Inc.
Axon Enterprise Inc is building a public safety operating system by integrating a suite of hardware devices and cloud software solutions. The company's suite includes cloud-hosted digital evidence management solutions, productivity and real-time operations software, body cameras, in-car cameras, TASER energy devices, drones and robotic security, and training solutions. The company's operation comprises of two operating segments, Software and Sensors, and TASER. The company generates the majority of its revenue from the Software and Sensors segment, which is engaged in developing, manufacturing, and selling fully integrated hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.